Fine Organic Industries Limited Earnings Summary — Q1 FY2027
Fine Organic Industries Reports Strong Q1 Performance with 18% Revenue Growth and 45% Net Profit Surge
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 3 consecutive quarters.
- Revenue of ₹694 Cr is 18.0% higher year-on-year.
- Revenue has compounded at 11.2% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit has reached its highest level in 10 quarters.
- Net profit of ₹138 Cr is 18.0% above the same quarter last year.
- Profit growth is trailing revenue growth this quarter.
- Net profit has compounded at 8.7% annualised across the period.
- Operating margin stands at 25.1% in Q1 FY2027.
- Operating margin expanded by 419 bps year-on-year.
- Over the last two years operating margin has contracted by 28 bps.
- PBT margin is 26.4%.
- Expense growth of 11.7% remained below revenue growth of 18.0%.
- Operating profit of ₹174 Cr is 41.7% higher year-on-year.
- Operating leverage continues to improve.
- 6 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 81/100 (Strong) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Improving | 694 | 625 | 555 | 597 | 588 | 607 | 517 | 596 | 550 | 547 |
| Expenses | Improving | 520 | 496 | 461 | 463 | 466 | 487 | 414 | 446 | 410 | 403 |
| Operating Profit | Accelerating | 174 | 129 | 94 | 134 | 123 | 120 | 103 | 150 | 139 | 144 |
| Operating Margin | Stable | 25.1% | 20.6% | 16.9% | 22.4% | 20.9% | 19.7% | 19.9% | 25.2% | 25.4% | 26.2% |
| Other Income | Improving | 24 | 35 | 21 | 21 | 47 | 26 | 25 | 22 | 25 | 22 |
| Interest | Volatile | 1 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| Depreciation | Stable | 14 | 18 | 14 | 13 | 12 | 15 | 13 | 13 | 12 | 15 |
| Profit Before Tax | Accelerating | 184 | 143 | 101 | 142 | 157 | 130 | 115 | 159 | 151 | 150 |
| Tax | Accelerating | 45 | 25 | 27 | 33 | 40 | 33 | 32 | 42 | 38 | 35 |
| Net Profit | Accelerating | 138 | 117 | 74 | 109 | 117 | 97 | 83 | 117 | 113 | 115 |
| Net Margin | Stable | 19.9% | 18.8% | 13.3% | 18.2% | 19.9% | 16.0% | 16.0% | 19.7% | 20.6% | 20.9% |
Key Takeaways
- Consolidated revenue grew 18% year-on-year to ₹694.17 crore, driven by steady demand in specialty chemical additives.
- Net profit witnessed a substantial 18% YoY increase, reaching ₹138.14 crore compared to ₹117.09 crore in the same period last year.
- Operational efficiency improved significantly, with Profit Before Tax (PBT) rising 28.5% quarter-on-quarter to ₹183.55 crore.
- The company maintains a pristine, virtually debt-free balance sheet with zero outstanding defaults on loans or debt securities.
- A long-standing insurance claim for property damage and inventory loss from a 2024 fire incident was finally settled in July 2026 for ₹4.35 crore.
- Consolidated earnings per share (EPS) improved to ₹45.06 from ₹38.19 in the year-ago quarter.
- Management continues to focus on 'green chemistry' and diversifying into high-margin segments like pharma additives and feed nutrition.
- Operating segments remain consolidated under 'Manufacturing of Specialty Chemicals', ensuring a focused business strategy.
Management Guidance
Management remains focused on product diversification into high-growth areas including feed nutrition and pharmaceutical additives, leveraging their deep technical expertise in oleochemical-based additives.
Sentiment Shift
Improving
The sharp recovery in profitability and revenue growth compared to both the prior year and sequential quarter indicates a successful navigation of recent cyclical normalization.
Outlook
The company is well-positioned for future regulatory shifts in EU/USA markets due to its green chemistry focus. Despite volatile raw material costs, the resilient 20%+ ROCE and strong cash position support continued capacity expansion and market share gains.
From the Annual Report (Key Quotes)
“The Company's business activity falls within a single primary business segment viz. 'Manufacturing of Specialty Chemicals'.”
“The insurance claim relating to property damage and inventory losses was finally settled at Rs. 4.35 crores in July 2026.”
“Fine Organic Industries continues to be a dominant niche player in the oleochemical-based additives market.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Fine Organic Industries Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.